Guggenheim Capital’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-149,777
| Closed | -$2.4M | – | 2968 |
|
|
2016
Q1 | $2.4M | Sell |
149,777
-30,767
| -17% | -$492K | 0.01% | 1453 |
|
|
2015
Q4 | $5.17M | Sell |
180,544
-33,280
| -16% | -$953K | 0.02% | 997 |
|
|
2015
Q3 | $6.09M | Buy |
213,824
+11,737
| +6% | +$334K | 0.02% | 945 |
|
|
2015
Q2 | $7.26M | Sell |
202,087
-9,933
| -5% | -$357K | 0.02% | 985 |
|
|
2015
Q1 | $6.16M | Buy |
212,020
+29,024
| +16% | +$844K | 0.01% | 1063 |
|
|
2014
Q4 | $3.86M | Buy |
182,996
+10,312
| +6% | +$217K | 0.01% | 1271 |
|
|
2014
Q3 | $3.35M | Sell |
172,684
-23,596
| -12% | -$457K | 0.01% | 1391 |
|
|
2014
Q2 | $3.07M | Buy |
+196,280
| New | +$3.07M | 0.01% | 1461 |
|
|
2013
Q4 | – | Sell |
-128,172
| Closed | -$1.5M | – | 3207 |
|
|
2013
Q3 | $1.5M | Buy |
+128,172
| New | +$1.5M | 0.01% | 1784 |
|